Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors

The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.

Saved in:
Bibliographic Details
Main Authors Falcone, Danielle, Zeng, Hongbo, Deng, Wei, Kong, Norman, Thompson, Christopher F, Bai, Yunfeng, Dinsmore, Christopher, Liu, Yumei, Zheng, Zhixiang, Katz, Jason David, Torres, Luis, Fuller, Peter, Fu, Jianmin, Guerin, David, Scott, Mark E
Format Patent
LanguageEnglish
Published 28.08.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
Bibliography:Application Number: US201414778055